SCHEMBL8796642

SCHEMBL8796642

CC1(C)CCC(C)(C)c2cc3cc(C=C(C(=O)O)c4cccc(Br)c4)ccc3cc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 5/20 0.66
PTGS2 P35354 1/20 0.54
AKR1C3 P42330 2/20 0.46
AKR1C2 P52895 1/20 0.46
RARB P10826 9/20 0.44
RARG P13631 9/20 0.44
RARA P10276 8/20 0.44
RXRA P19793 4/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP26A1 O43174 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
GMNN O75496 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796638 1.00 PLA2G4A (0.66) PLA2G4APTGS2AKR1C3AKR1C2RARB
SCHEMBL8795964 0.90 PTGS2 (0.57) PLA2G4APTGS2AKR1C3AKR1C2RARB
SCHEMBL8795957 0.90 PTGS2 (0.57) PLA2G4APTGS2AKR1C3AKR1C2RARB
SCHEMBL8795959 0.84 PLA2G4A (0.60) PLA2G4APTGS2AKR1C3AKR1C2RARB
SCHEMBL8795946 0.84 PLA2G4A (0.60) PLA2G4APTGS2AKR1C3AKR1C2RARB
SCHEMBL8796153 0.81 PLA2G4A (0.51) PLA2G4APTGS2RARBRARGRARA
SCHEMBL8796157 0.81 PLA2G4A (0.51) PLA2G4APTGS2RARBRARGRARA
Bicarbonate SCHEMBL6673968 0.81 PLA2G4A (0.83) PLA2G4ARARBRARGRARARXRA
SCHEMBL8796502 0.80 PLA2G4A (1.00) PLA2G4ARARBRARGRARARXRA
SCHEMBL8796499 0.80 PLA2G4A (1.00) PLA2G4ARARBRARGRARARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed